Long-Term Follow-Up of Cancer Survivors Who Were Previously Enrolled in a Center for Cancer Research Study - Full Text View

Sponsor:	National Cancer Institute (NCI)
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00296075

Purpose

RATIONALE: Follow-up of long-term cancer survivors who participated in a clinical trial may help health professionals better understand their disease and determine the long-term effects of treatment.

PURPOSE: This clinical trial is studying long-term cancer survivors to monitor their cancer and determine the effects of previous treatment.

Condition	Intervention
Long-Term Effects Secondary to Cancer Therapy in Adults Long-Term Effects Secondary to Cancer Therapy in Children Unspecified Childhood Solid Tumor, Protocol Specific Unspecified Adult Solid Tumor, Protocol Specific	Procedure: complications of therapy assessment/management Procedure: diagnostic imaging Procedure: diagnostic radiology Procedure: observation Procedure: supportive care/therapy

Study Type:	Observational
Study Design:	Natural History
Official Title:	Study of Long-Term Follow-Up in Cancer Survivors Who Were Previously Enrolled on a Center for Cancer Research Protocol

Resource links provided by NLM:

MedlinePlus related topics: Cancer

U.S. FDA Resources

Further study details as provided by National Cancer Institute (NCI):

Detailed Description:

OBJECTIVES:

Provide follow-up visits for previously enrolled Center for Cancer Research patients who are long-term survivors and may not be currently entered on an active protocol.

OUTLINE: This is a follow-up study.

Patients undergo long-term standard tests and procedures, including laboratory tests, diagnostic radiography, and nuclear medicine studies based on the patient's diagnosis, prior therapy, and supporting clinical information, to follow course of disease and effects of prior therapies until the patient enters another active primary protocol OR follow-up is no longer required at the Center for Cancer Research.

PROJECTED ACCRUAL: A total of 1,000 patients will be accrued for this study.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

DISEASE CHARACTERISTICS:

Previously enrolled on a Center for Cancer Research (CCR) protocol
Not eligible for or unwilling to participate in an active NCI intramural primary research protocol
Deemed best suited for follow-up at the National Institute of Health by CCR investigator

PATIENT CHARACTERISTICS:

Not specified

PRIOR CONCURRENT THERAPY:

No concurrent investigational therapies or other treatments with therapeutic intent for the disease under observation
No concurrent procedures that would entail more than minimal risk to the patient

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00296075

Locations

United States, Maryland
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Bethesda, Maryland, United States, 20892-1182

Sponsors and Collaborators

National Cancer Institute (NCI)

Investigators

Principal Investigator:

Frank M. Balis, MD

NCI - Pediatric Oncology Branch

More Information

Additional Information:

Clinical trial summary from the National Cancer Institute's PDQ® database This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	CDR0000078655, NCI-96-C-0071G
Study First Received:	February 23, 2006
Last Updated:	December 4, 2006
ClinicalTrials.gov Identifier:	NCT00296075 History of Changes
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Neoplasms
Neoplastic Processes
Pathologic Processes
Neoplasm Metastasis

ClinicalTrials.gov processed this record on November 27, 2009